Venture Capital
How Does Venture Capital Shape Biotech Innovation?
In new research, Xuelin Li, Sijie Wang, Jiajie Xu, and Xiang Zheng find that the involvement of specialized venture capital firms influences a biotech startup’s drug portfolio by focusing research and development on fewer products.
Lower Antitrust Enforcement Reduces Venture Capital Investment and Startup Innovation
In new research, Wentian Zhang finds that a reduction in antitrust enforcement causes venture capitalists to significantly decrease their investments in startups, leading to fewer startups going public and diminished innovation.
Bethany McLean’s Weekend Reading List: Flash Crash, Alaska, and Venture Capital
Corruption, lobbying, corporate malfeasance, and frauds: a weekly unconventional selection of must-read articles by investigative journalist Bethany McLean.Â
Remember the flash crash of 2010? Here's...
A Tale of Hubris and Excess: How Uber Fooled Portland Regulators
In an excerpt from his new book "Super Pumped: The Battle for Uber," New York Times reporter Mike Isaac reveals the details of Uber's...
The Counterfeit Capitalism of WeWork: Predatory Pricing as a Business Model
The company failed to go public and its founder, Adam Neumann, had to step down. This is good news: ordinary investors refused to put...
The Problem With Unicorns: Why Investors Stopped WeWork From Going Public
More and more startups are valued at over $1 billion, even if they have dysfunctional corporate structures and hazardous business models. For tech companies,...
If You Don’t Think Today’s Tech Giants Are Vicious, Just Ask Venture Capitalists
Silicon Valley today resembles the deepest part of the jungle known as the triple canopy, where tall trees block out all the light and...
Where Will the Crypto Craze Lead? A Venture Capitalist’s View
Can individual cryptocurrencies be programmed with stability in mind and if so, could a plethora of cryptocurrencies exhibit, in the aggregate, stable behaviors?
By now,...
